Navigation Links
VHA Foundation Launches National CEO Patient SafetyNetwork, Starting From the Top to Make Patients Safer
Date:5/6/2008

New Survey Finds that Hospital CEOs Recognize Patients' Safety Concerns, But Lack Confidence About Best Ways to Create Safer Environment

PHILADELPHIA, May 6 /PRNewswire-USNewswire/ -- As patient safety incidents in America's hospitals continue to gain prominence, a new survey shows that few hospital CEOs feel strongly confident about practices in place to prevent or manage these incidents. In response, the VHA Foundation today formally launched the "Health Care SafetyNetwork," a national program to open dialogue among hospital CEOs in an area where most have little formal training. The two-year initiative offers CEOs a forum where they can learn from peers and patient safety experts about ways to create a culture that emphasizes safety above all else.

"Given what we know about the growing number of patient safety incidents, it is not a matter of if medical errors will happen in a given hospital, but when and where," said Ken Smithson, M.D., Vice President of Clinical Improvement Services at VHA Inc. "Yet, hospital leaders are not as confident as they should be when it comes to being prepared to manage a patient safety event - or prevent one from happening in the first place."

New research released today by the VHA Foundation demonstrates the need for a patient safety resource specifically designed for CEOs. The national survey of hospital CEOs revealed that while more than two-thirds (68 percent) of hospital leaders have faced a significant patient safety event in the last three years, only small percentages reported feeling strongly confident about the practices put in place to prevent incidents and in their skills needed to handle one.

-- 15 percent strongly agreed that safety improvements are effectively

implemented and monitored.

-- 20 percent strongly agree that they are confident when speaking with a

patient's family regarding a patient safety related incident.

-- 18 percent str
'/>"/>

SOURCE VHA Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. National Patient Safety Foundation Partners with Vocera Communications
2. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
3. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
4. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
7. The Tug McGraw Foundation Announces 2007 Fundraising Gala
8. The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia
9. Cipla, Tell the Truth; AIDS Healthcare Foundation Launches New Ad Campaign
10. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
11. Exceptional Childrens Foundation Merger with Kayne Eras Center Creates One of States Most Comprehensive Nonprofits Serving the Disabled

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , CHICAGO Targeted breast ultrasound of suspici...e, reliable and cost-effective alternative to inva... the findings of two studies presented today at th...rth America (RSNA). , "By performing high-qualit...xpensive and avoidable invasive diagnostic procedu...
(Date:12/2/2009)... , CHICAGO Results of a large-scale clinical tri...diological Society of North America (RSNA) provide...l screening ultrasound for women with dense breast...ddition, the study confirmed that MRI is highly se...found that annual screening with ultrasound in add...
(Date:12/1/2009)... , Advocate Christ Medica...quo;s newest kidney transplant center and the firs... following formal approval of the hospital’s...acilities and Services Review Board. , ...te Christ Medical Center in Oak Lawn, Ill. has be...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire/ ...search report is available in its catalogue: ,,...erapeutics - Market Forecasts to 2015, Competitive... ,, http://www.reportlinker.com/p0166814/The-...tics---Market-Forecasts-to-2015-Competitive-Benchm...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire/...esearch report is available in its catalogue: ,...recasts to 2015, Competitive Benchmarking, Product...portlinker.com/p0166816/The-Future-of-Monoclonal-A...enchmarking-Product-Pipeline-and-Deals-Analysis.ht...
Breaking Medicine News(10 mins):Health News:Targeted breast ultrasound can reduce biopsies for women under 40 2Health News:Annual screening with breast ultrasound or MRI could benefit some women 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11
... Park Ridge, Ill. (April 3, 2008) Choline, an ess...sociated with a 24 percent reduced risk of breast ...from the U.S. National Institutes of Health (NIH),...ed risk of breast cancer. , In this new case-con...
... With Australia,s ageing population, diseases lik...llion in recent grants, The University of Queensla...th a range of dementia-related issues. , Three U...ons to residential care and ascertaining the capac...
...OMERSET, N.J., April 3, 2008 TeamStaff, Inc.,(Nas... administrative,staffing services, today announced...nded and restated loan and security agreement with...es,assignment of TeamStaff,s prior revolving credi...
...RVINE, Calif., April 3, 2008 Edwards,Lifesciences...ucts and,technologies to treat advanced cardiovasc...d chief executive officer, Michael A. Mussallem, h...ed last,month., The new plan will provide a vehic...
...tudy finds 65% with college degree made attempt, b...RSDAY, April 3 (HealthDay News) -- TV ads that pro...mpact on better-educated smokers, while warnings a...003, researchers surveyed 452 adult smokers of dif...
...EIJING, April 3, 2008 /Xinhua-PRNewswire-FirstCall...y") (Nasdaq: CMED ), a leading China-based,medica...arkets advanced,in-vitro diagnostic products and h...Kit"), a prostate cancer-specific,molecular diagno...
Other Medicine News:Health News:Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 2Health News:Essential nutrient found in eggs reduces risk of breast cancer by 24 percent 3Health News:Better care for dementia patients through new funding 2Health News:TeamStaff Announces Amended Revolving Credit Facility with Sovereign Business Capital 2Health News:TeamStaff Announces Amended Revolving Credit Facility with Sovereign Business Capital 3Health News:Edwards Lifesciences' Chairman and CEO Adopts New 10b5-1 Stock Trading Plan to Replace Recently Expired Plan 2Health News:Better-Educated Smokers More Likely to Quit After Seeing Ads 2Health News:China Medical Technologies Completed the Development of Prostate Cancer FISH Reagent 2
(Date:12/1/2009)... Dec. 1 Former New Jerse...ighted when his radiotherapy treatment sessions fo...day to less than five. Midway through his course ...ogy Cancer Center acquired the region,s first R... Medical Systems (NYSE: VAR ), making it possibl...
(Date:12/1/2009).... 1 Galenea Corp. and Otsuka Pharm...tension of their research and development collabor...es the collaboration term to seven years and bring... million. The companies have been working togethe...and developing first-in-class therapies for schizo...
(Date:12/1/2009)...ewswire/ -- BioInformatics, LLC announces the rele... Research Products in FY2010. The 8.2 billion do...program by the American Recovery and Reinvestment ... Challenge Grants, the Shared Instrumentation Prog...n-profit institutions, all of which will have an i...
Breaking Medicine Technology:Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 2BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010 3Morphotek 28R 29 Inc and Cancer Innovations Inc Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies 13039 1Morphotek 28R 29 Inc and Cancer Innovations Inc Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies 13039 2Morphotek 28R 29 Inc and Cancer Innovations Inc Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies 13039 3Smart for Life 28TM 29 Featured in Womans World Magazine 51752 1Smart for Life 28TM 29 Featured in Womans World Magazine 51752 2Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 1Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 2Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 3Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 4Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 5Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 6Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 7Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 8Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 9Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 10Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 11Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 12Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 13Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 14Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 15Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 16Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 17Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 18Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 19Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 20Abbott Reports Strong Second Quarter Results 3B Confirms Double Digit Earnings Growth Outlook for 2009 51750 21
Storz Twisted Snare Wire
Hunkeler IOL Snare
Nichamin Fixation Ring and Gauge
Mertz Keratoscopy Ring
Medicine Products: